Metraipolis › archive › dc_5b9c8fe61981

SARS-CoV-2 mRNA Vaccine Effectiveness in the Borriana COVID-19 Cohort: A Prospective Population-Based Cohort Study — Europe PMC PMID:41562678

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41562678
DOI
10.3390/epidemiologia7010001
License (as archived)
solo-consultazione
Archived
2026-11-07T12:56:04.039Z
SHA-256 of the archived text
b8a0a1b4c60d22de0841e72a7eb9b76a3b7e8d8f2691a6391f19df6e0e03d932
Stable URL of this page
https://metraipolis.com/documento/dc_5b9c8fe61981

How to cite

SARS-CoV-2 mRNA Vaccine Effectiveness in the Borriana COVID-19 Cohort: A Prospective Population-Based Cohort Study — Europe PMC PMID:41562678 — Europe PMC (en), https://europepmc.org/article/MED/41562678 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5b9c8fe61981 (Metraipolis archive dc_5b9c8fe61981, sha256 b8a0a1b4c60d22de0841e72a7eb9b76a3b7e8d8f2691a6391f19df6e0e03d932)
BibTeX
@misc{dc5b9c8fe61981,
  title = {SARS-CoV-2 mRNA Vaccine Effectiveness in the Borriana COVID-19 Cohort: A Prospective Population-Based Cohort Study — Europe PMC PMID:41562678},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41562678},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5b9c8fe61981; sha256 b8a0a1b4c60d22de0841e72a7eb9b76a3b7e8d8f2691a6391f19df6e0e03d932},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41562678. Agents can read the archived copy with the MCP tool read_document.